ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.64
0.22%
US Tech 100
20,266.40
0.33%
S&P 500
5,969.34
0.35%
US Dollar vs CAD
1.39805
-0.03%
Bitcoin
98,901.15
-0.13%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Pfizer Inc (0Q1N)

  7. Pfizer Inc (0Q1N) News

0Q1N

Pfizer (0Q1N)

Pfizer Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0Q1N
DateTimeSourceHeadlineSymbolCompany
10/29/20249:31AMAlliance NewsAlliance NewsHundreds of blood cancer patients to benefit from new Pfizer treatmentLSE:0Q1NPfizer Inc
10/29/20246:46AMAlliance NewsAlliance NewsTOP NEWS: Pfizer swings to third-quarter profit as Paxlovid sales jumpLSE:0Q1NPfizer Inc
10/03/202411:29AMAlliance NewsAlliance NewsIN BRIEF: Haleon buys GBP230 million in shares from PfizerLSE:0Q1NPfizer Inc
10/01/20244:03AMAlliance NewsAlliance NewsUPDATE: Pfizer cuts stake in Haleon to 15% with GBP2.7 billion saleLSE:0Q1NPfizer Inc
09/30/20243:59PMAlliance NewsAlliance NewsTOP NEWS: Pfizer to raise around GBP2.7 billion from Haleon stake saleLSE:0Q1NPfizer Inc
09/25/20247:49AMAlliance NewsAlliance NewsPfizer, Moderna and BioNTech take patent fight to Court of AppealLSE:0Q1NPfizer Inc
09/16/20245:00AMAlliance NewsAlliance NewsPfizer hails positive results from two cancer treatment studiesLSE:0Q1NPfizer Inc
07/30/20246:35AMAlliance NewsAlliance NewsTOP NEWS: Pfizer ups outlook amid first revenue hike since Covid boostLSE:0Q1NPfizer Inc
05/01/20247:42AMAlliance NewsAlliance NewsTOP NEWS: Pfizer profit declines on lower Covid-related salesLSE:0Q1NPfizer Inc
04/23/202412:27AMAlliance NewsAlliance NewsModerna, Pfizer/BioNTech set for UK court clash over Covid jab patentsLSE:0Q1NPfizer Inc
04/09/202412:41PMAlliance NewsAlliance NewsPfizer RSV treatment meets targets in trial of adults under age 60LSE:0Q1NPfizer Inc
03/21/202411:29AMAlliance NewsAlliance NewsTOP NEWS: Haleon buys back shares worth GBP315 million from PfizerLSE:0Q1NPfizer Inc
03/19/20245:17AMAlliance NewsAlliance NewsHaleon to buy back shares from Pfizer for GBP315 millionLSE:0Q1NPfizer Inc
03/18/20243:47AMAlliance NewsAlliance NewsTOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in HaleonLSE:0Q1NPfizer Inc
03/13/202411:28AMAlliance NewsAlliance NewsIN BRIEF: EU approves Pfizer's Prevenar in children with pneumococcalLSE:0Q1NPfizer Inc
03/01/202412:27PMAlliance NewsAlliance NewsPfizer targets eight blockbuster drugs by 2030 in new oncology planLSE:0Q1NPfizer Inc
01/30/20246:56AMAlliance NewsAlliance NewsTOP NEWS: Pfizer backs outlook but 2023 profit falls after Covid boostLSE:0Q1NPfizer Inc
01/29/20242:26AMAlliance NewsAlliance NewsAstellas and Pfizer's Padcev validated by EMA to treat bladder cancerLSE:0Q1NPfizer Inc
01/09/20247:49AMAlliance NewsAlliance NewsPfizer's licence application accepted for priority review of TivdakLSE:0Q1NPfizer Inc
01/08/202412:09PMAlliance NewsAlliance NewsIN BRIEF: Pfizer wins European approval for prostate cancer treatmentLSE:0Q1NPfizer Inc
12/19/20238:13AMAlliance NewsAlliance NewsTOP NEWS: Pfizer sues Poland and Hungary over Covid debtsLSE:0Q1NPfizer Inc
12/18/20235:04AMAlliance NewsAlliance NewsAstellas, Merck, Pfizer celebrate US approval for Keytruda plus PadcevLSE:0Q1NPfizer Inc
12/13/202310:11AMAlliance NewsAlliance NewsTOP NEWS: Pfizer shares slide as 2024 revenue outlook underwhelmsLSE:0Q1NPfizer Inc
12/12/20236:35AMAlliance NewsAlliance NewsPfizer's USD43 billion Seagen buy given regulatory nodLSE:0Q1NPfizer Inc
12/11/20233:08AMAlliance NewsAlliance NewsPfizer's Elrexfio wins EU approval for form of multiple myelomaLSE:0Q1NPfizer Inc
12/01/202310:54AMAlliance NewsAlliance NewsTOP NEWS: Pfizer rethinks weight loss pill after high side effect rateLSE:0Q1NPfizer Inc
11/14/202311:55PMAlliance NewsAlliance NewsPfizer to axe 500 jobs at Kent site amid cost-cutting programmeLSE:0Q1NPfizer Inc
10/31/20236:45AMAlliance NewsAlliance NewsTOP NEWS: Pfizer outlook downbeat as swings to loss in third quarterLSE:0Q1NPfizer Inc
10/20/20233:25PMAlliance NewsAlliance NewsUS FDA approves Pfizer's Penbraya for meningococcal diseaseLSE:0Q1NPfizer Inc
10/19/202310:37AMAlliance NewsAlliance NewsEU clears Pfizer's USD43 billion takeover of biotech firm SeagenLSE:0Q1NPfizer Inc
 Showing the most relevant articles for your search:LSE:0Q1N

Your Recent History

USOTC
CBDW
1606 (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
NLST
Netlist (QB)
USOTC
MVNT
Movement Industries (PK)
USOTC
APRU
Apple Rush (PK)
USOTC
GDVM
Global Developments (PK)
COIN
DOGEUSD
Dogecoin
USOTC
PHIL
PHI (PK)
USOTC
SINC
Sincerity Applied Materi... (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
RDAR
Raadr (PK)
NASDAQ
COOP
Mr Cooper
USOTC
ERHE
ERHC Energy (CE)
USOTC
AZRH
Azure (PK)
NASDAQ
HALO
Halozyme Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved